LifeWealth Investments LLC Invests $97,000 in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

LifeWealth Investments LLC bought a new position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund bought 10,433 shares of the pharmacy operator’s stock, valued at approximately $97,000.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Vanguard Group Inc. increased its position in Walgreens Boots Alliance by 2.7% during the 4th quarter. Vanguard Group Inc. now owns 86,335,084 shares of the pharmacy operator’s stock worth $805,506,000 after buying an additional 2,279,495 shares during the period. Invesco Ltd. raised its stake in Walgreens Boots Alliance by 8.8% in the 4th quarter. Invesco Ltd. now owns 32,572,567 shares of the pharmacy operator’s stock worth $303,902,000 after purchasing an additional 2,631,332 shares in the last quarter. Geode Capital Management LLC boosted its holdings in Walgreens Boots Alliance by 5.2% in the 4th quarter. Geode Capital Management LLC now owns 20,779,254 shares of the pharmacy operator’s stock valued at $194,082,000 after purchasing an additional 1,020,587 shares during the period. Charles Schwab Investment Management Inc. increased its holdings in shares of Walgreens Boots Alliance by 19.9% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 13,155,138 shares of the pharmacy operator’s stock worth $122,737,000 after purchasing an additional 2,185,950 shares during the period. Finally, Northern Trust Corp increased its holdings in shares of Walgreens Boots Alliance by 18.8% during the fourth quarter. Northern Trust Corp now owns 8,896,742 shares of the pharmacy operator’s stock worth $83,007,000 after purchasing an additional 1,407,973 shares during the period. Institutional investors and hedge funds own 58.59% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on the company. Wall Street Zen started coverage on Walgreens Boots Alliance in a research report on Wednesday, May 21st. They set a “hold” rating on the stock. Deutsche Bank Aktiengesellschaft downgraded Walgreens Boots Alliance from a “hold” rating to a “sell” rating and cut their target price for the company from $11.00 to $9.00 in a research report on Friday, February 28th. Wolfe Research upgraded Walgreens Boots Alliance to a “hold” rating in a research report on Monday, February 24th. Finally, Truist Financial cut their price objective on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating for the company in a research report on Friday, January 31st. Four equities research analysts have rated the stock with a sell rating, seven have given a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $10.59.

Insider Transactions at Walgreens Boots Alliance

In other news, Chairman Stefano Pessina purchased 832,258 shares of the business’s stock in a transaction dated Sunday, April 27th. The shares were purchased at an average cost of $11.01 per share, with a total value of $9,163,160.58. Following the completion of the purchase, the chairman now owns 145,621,079 shares of the company’s stock, valued at $1,603,288,079.79. This trade represents a 0.57% increase in their position. The purchase was disclosed in a document filed with the SEC, which is available at this link. Company insiders own 17.50% of the company’s stock.

Walgreens Boots Alliance Stock Down 0.6%

Shares of NASDAQ WBA opened at $11.17 on Tuesday. The company has a market cap of $9.66 billion, a price-to-earnings ratio of -1.09, a PEG ratio of 1.31 and a beta of 0.77. The company has a current ratio of 0.64, a quick ratio of 0.30 and a debt-to-equity ratio of 0.68. Walgreens Boots Alliance, Inc. has a 12 month low of $8.08 and a 12 month high of $16.34. The stock has a 50-day moving average price of $11.02 and a two-hundred day moving average price of $10.44.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings data on Tuesday, April 8th. The pharmacy operator reported $0.63 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.53 by $0.10. The business had revenue of $38.59 billion during the quarter, compared to analysts’ expectations of $37.90 billion. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The firm’s quarterly revenue was up 4.1% compared to the same quarter last year. During the same period in the prior year, the company earned $1.20 EPS. As a group, analysts forecast that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current fiscal year.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.